tiprankstipranks
Hims & Hers Health (DE:82W)
FRANKFURT:82W
Germany Market
82W
Hims & Hers Health
RESEARCH TOOLSreports

Hims & Hers Health (82W) Stock News & Sentiment

Compare
36 Followers
Buy Rating on Hims & Hers: Undervalued Growth Leveraging Novo Nordisk GLP-1 Partnership and Scale Advantages
Premium
Ratings
Buy Rating on Hims & Hers: Undervalued Growth Leveraging Novo Nordisk GLP-1 Partnership and Scale Advantages
2d ago
HIMS
HIMS Stock Slides after Wegovy Subscription Launch; BofA Sees 31% Drop in GLP-1 Franchise
Premium
Market News
HIMS Stock Slides after Wegovy Subscription Launch; BofA Sees 31% Drop in GLP-1 Franchise
3d ago
BAC
NVO
Hims, Novo, CrowdStrike, SolarEdge, Telus Trending With Analysts
Premium
Weekend Updates
Hims, Novo, CrowdStrike, SolarEdge, Telus Trending With Analysts
15d ago
TU
NVO
Hims & Hers (HIMS) Stock Rallies 58% in Five Days — Can the Momentum Last?
Premium
Market News
Hims & Hers (HIMS) Stock Rallies 58% in Five Days — Can the Momentum Last?
17d ago
NVO
HIMS
Hims & Hers revamps GLP-1 strategy with Novo Nordisk
Premium
Company Announcements
Hims & Hers revamps GLP-1 strategy with Novo Nordisk
17d ago
8K
HIMS
HIMS-Novo ‘Can’t Quit Each Other’ – Analysts Bullish on Wegovy Deal
Premium
Market News
HIMS-Novo ‘Can’t Quit Each Other’ – Analysts Bullish on Wegovy Deal
18d ago
NVO
HIMS
Re-Rating Hims & Hers: Novo Nordisk Partnership De-Risks GLP-1 Exposure and Supports Further Multiple Expansion
Premium
Ratings
Re-Rating Hims & Hers: Novo Nordisk Partnership De-Risks GLP-1 Exposure and Supports Further Multiple Expansion
19d ago
HIMS
More DE:82W News >

82W News on the Web

Hims & Hers price target lowered to $23 from $25 at TD Cowen
TipRanks News
Bearish
Buy Rating on Hims & Hers: Undervalued Growth Leveraging Novo Nordisk GLP-1 Partnership and Scale Advantages
TipRanks News
Bullish
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Meiragtx Holdings (MGTX), Hims & Hers Health (HIMS) and Siemens Healthineers AG (OtherSEMHF)
TipRanks News
Neutral
Hims & Hers Expands Access to FDA-Approved GLP-1 Medications Through Novo Nordisk Collaboration
Market Chameleon
Neutral
Hims & Hers Expands Access To Novo Nordisk's FDA-Approved GLP-1 Medications, Including Wegovy Pill
rttnews
Bullish
Hims & Hers shifts business model after Novo deal
TheStreet.com
Bullish
HIMS Stock Slides after Wegovy Subscription Launch; BofA Sees 31% Drop in GLP-1 Franchise
TipRanks News
Bearish
Private Markets: OpenAI raises additional $10B funding
TipRanks News
Neutral

News Score - Last 7 Days

Negative
DE:82W
Sector Average
Media Buzz
This Week23 articles
Weekly Average37.25 articles
News Sentiment
This Week47%
Sector Average67%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:82W’s Media Buzz Sentiment?
23 articles about DE:82W were published this week. In an average week, 37.25 articles are published.
    What is DE:82W’s weekly average amount of articles?
    In an average week, 37.25 articles about DE:82W are published.
      What is DE:82W’s News Sentiment?
      47% of articles about DE:82W were positive this week, compared to its sector average of 67%.
        Healthcare Stocks that are Trending in the News
        PYXSPyxis Oncology
        WXIBFWuxi Biologics (Cayman)
        KODKodiak Sciences
        SHTDYSinopharm Group Co
        GILDGilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S
        Showing the stocks with the most bullish news sentiment over the past week